Literatur
- 1
Alcalay J, Freeman S E, Goldberg L H, Kripke M L, Wolf J E.
Decreased excision repair of pyrimidine dimers induced in the skin of basal
cell carcinoma patients by simulated solar radiation.
J Invest Dermatol.
1990;
94
502
- 2
Asada M, Korge B, Almeida H. et al .
Solid basal cell epithelioma possibly originates from the lower part of the
outer root sheath.
Zbl Haut.
1991;
158
2320
- 3
Bath F J, Bong J, Perkins W, Williams H C.
Interventions for basal cell carcinoma of the skin.
Cochrane Database Syst Rev.
2003;
2
CD003412
- 4
Blum A, Metzler G, Hofmann-Wellenhof R, Soyer H P, Garbe C, Bauer J.
Correlation between dermoscopy and histopathology in pigmented and non-pigmented
skin tumours.
Hautarzt.
2003;
54
279-291
- 5
Bavinck J N, Bastiaens M T, Marugg M E. et al .
Further evidence for an association of HLA-DR7 with basal cell carcinoma on
the tropical island of Saba.
Arch Dermatol.
2000;
136
1019-1022
- 6
Breuninger H, Garbe K.
Basalazellkarzinom.
Hautarzt.
1998;
10
S15-19
- 7
Calista D.
Topical 1 % cidofovir for the treatment of basal cell carcinoma.
Eur J Dermatol.
2002;
12
562-564
- 8
Czarnecki D, Lewis A, Nicholson I, Tait B.
Multiple basal cell carcinomas and HLA frequencies in southern Australia.
J Am Acad Dermatol.
1991;
24
559-561
- 9
Danopoulos E D, Danopoulou I E.
Regression of liver cancer with oral urea.
Lancet.
1974;
1
132
- 10
D’Errico M, Calcagnile A S, Corona R. et al .
p53 mutations and chromosome instability in basal cell carcinomas developed
at an early or late age.
Cancer Res.
1997;
57
747-752
- 11
Euvrard S, Kanitakis J, Claudy A.
Skin cancers after organ transplantation.
N Engl J Med.
2003;
348
1681-1691
- 12
George R, Weightman W, Russ G R, Bannister K M, Mathew T H.
Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant
recipients.
Australas J Dermatol.
2002;
43
269-273
- 13
Giuffrida T J, Jimenez G, Nouri K.
Histologic cure of basal cell carcinoma treated with cryosurgery.
J Am Acad Dermatol.
2003;
49
483-486
- 14
Greinert R, Volkmer B, Wende A, Voss S, Breitbart E W.
Prävention von Hautkrebs. Notwendigkeit, Durchführung und Erfolg.
Hautarzt.
2003;
54
1152-1163
- 15
Kanitakis J, Alhaj-Ibrahim L, Euvrard S, Claudy A.
Basal cell carcinomas developing in solid organ transplant recipients: clinicopathologic
study of 176 cases.
Arch Dermatol.
2003;
139
1133-1137
- 16
Katiyar S K, Ahmad N, Mukhtar H.
Green tea and skin.
Arch Dermatol.
2000;
136
989-994
- 17
Kim K H, Yavel R M, Gross V L, Brody N.
Intralesional Interferon alpha-2b in the Treatment of Basal Cell Carcinoma and
Squamous Cell Carcinoma: Revisited.
Dermatol Surg.
2004;
30
116-120
- 18
Kopf A.
Computer analysis of 3531 basalcell carcinomas of the skin.
J Derm.
1979;
6
267-281
- 19
Kowalzick L, Rogozinski T, Wimheuer R. et al .
Intralesional recombinant interferon beta-1a in the treatment of basal cell
carcinoma: results of an open-label multicentre study.
Eur J Dermatol.
2002;
12
558-561
- 20
Kumar P, Watson S, Brain A N. et al .
Incomplete excision of basal cell carcinoma: a prospective multicentre audit.
Br J Plast Surg.
2002;
55
616-622
- 21
Lear J T, Smith A G.
Basal cell carcinoma.
Postgrad Med J.
1997;
73
538-542
- 22
Levi F, La Vecchia C, Te V C, Randimbison L, Erler G.
Incidence of invasive cancers following basal cell skin cancer.
Am J Epidemiol.
1998;
147
722-726
- 23
Marmur E S, Schmults C D, Goldberg D J.
A review of laser and photodynamic therapy for the treatment of nonmelanoma
skin cancer.
Dermatol Surg.
2004;
30
264-271
- 24
Miller S J.
Biology of basal cell carcinoma (Part I).
J Am Acad Dermatol.
1991;
24
1-13
- 25
Moore J V, Allan E.
Pulsed ultrasound measurements of depth and regression of basal cell carcinomas
after photodynamic therapy: relationship to probability of 1-year local control.
Br J Dermatol.
2003;
149
1035-1040
- 26
Nagore E, Grau C, Molinero J, Fortea J M.
Positive margins in basal cell carcinoma: relationship to clinical features
and recurrence risk. A retrospective study of 248 patients.
J Eur Acad Dermatol Venereol.
2003;
17
167-170
- 27
Nékám L.
Basalioma adenoides cysticum esete.
Orvosi Hetilap.
1901;
39
1-10
- 28
Nickoloff B J, Qin J Z, Chaturvedi V, Bacon P, Panella J, Denning M F.
Life and death signaling pathways contributing to skin cancer.
J Invest Dermatol Symp Proc.
2002;
7
27-35
- 29
Nijsten T E, Stern R S.
The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet
A: a cohort study.
J Invest Dermatol.
2003;
121
252-258
- 30
Peterson S R, Goldberg L H.
New and emerging treatments for nonmelanomas and actinic keratoses.
J Drugs Dermatol.
2003;
2
429-432
- 31
Pfeiffer P, Hansen O, Rose C.
Systemic cytotoxic therapy of basal cell carcinoma. A review of the literature.
Eur J Cancer.
1990;
26
73-77
- 32
Pfister R.
Antibiotische Behandlung maligner epthelialer Tumoren.
Fortschr Med.
1977;
12
784-787
- 33
Reyman F.
Treatment of basal cell carcinoma of the skin with 5-Fluorouracil ointment.
A 10-year follow-up study.
Dermatologica.
1979;
158
368-372
- 34
Rhodes L E, de Rie M, Enstrom Y. et al .
Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular
basal cell carcinoma: results of a multicenter randomized prospective trial.
Arch Dermatol.
2004;
140
17-23
- 35
Robins W.
Chemosurgery: My 15 years of experimence.
J Dermatol Surg Oncol.
1981;
9
79-789
- 36
Rozylo-Kalinowska I, Rozylo T K.
Odontogenic keratocyst in Gorlin-Goltz syndrome.
Ann Univ Mariae Curie Sklodowska.
2002;
57
79-85
- 37
Safai B, Good R A.
Basal cell carcinoma with metastasis. Review of the literature.
Arch Pathol Lab Med.
1977;
101
327-331
- 38
Schon M, Bong A B, Drewniok C. et al .
Tumor-selective induction of apoptosis and the small-molecule immune response
modifier imiquimod.
J Natl Cancer Inst.
2003;
95
1138-1149
- 39
Seegenschmiedt M H, Oberste-Beulmann S, Lang E, Lang B, Guntrum F, Olschewski T.
Strahlentherapie des Basalzellkarzinoms.
Strahlenther Onkol.
2001;
177
240-246
- 40
Smyth I, Narang M A, Evans T. et al .
Isolation and characterization of human patched 2 (PTCH2), a putative tumour
suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32.
Hum Mol Genet.
1999;
8
291-297
- 41
Spates S T, Mellette J R, Fitzpatrick J.
Metastatic basal cell carcinoma.
Dermatol Surg.
2003;
29
650-652
- 42
Szeimies R M, Landthaler M.
Photodynamic therapy and fluorescence diagnosis of skin cancers.
Recent Results Cancer Res.
2002;
160
240-245
- 43
Tangrea J A, Edwards B K, Taylor P R. et al .
Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma:
a multicenter clinical trial. Isotretinoin-Basal Cell Carcinoma Study Group.
J Natl Cancer Inst.
1992;
84
328-332
- 44
Thissen M R, Neumann M H, Schouten L J.
A systematic review of treatment modalities for primary basal cell carcinomas.
Arch Dermatol.
1999;
135
1177-1183
- 45
Thomas D J, King A R, Peat B G.
Excision margins for nonmelanotic skin cancer.
Plast Reconstr Surg.
2003;
2
57-63
- 46
Tran H, Chen K, Shumack S.
Epidemiology and aetiology of basal cell carcinoma.
Br J Dermatol.
2003;
149
50-52
- 47
Van Scott E G, Reinertson R P.
The modulating influence of stromal environment on epithelial cells studied
in human autotransplants.
J Invest Dermatol.
1961;
39
183-189
- 48
von Domarus H, Stevens P J.
Metastatic basal cell carcinoma. Report of five cases and review of 170 cases
in the literature.
J Am Acad Dermatol.
1984;
10
1043-1060
- 49
Wallberg P, Skog E.
The incidence of basal cell carcinoma in an area of Stockholm County during
the period 1971 - 1980.
Acta Derm Venereol.
1991;
71
134-137
- 50
Zeitouni N C, Oseroff A R, Shieh S.
Photodynamic therapy for nonmelanoma skin cancers. Current review and update.
Mol Immunol.
2003;
39
1133-1136
Dr. med. Joachim Dissemond
Universitätsklinikum Essen, Klinik und Poliklinik für Dermatologie, Venerologie
und Allergologie
Hufelandstraße 55
45122 Essen
Telefon: 0201/7233894
Fax: 0201/7235935
eMail: joachimdissemond@hotmail.com
